These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 29352424)

  • 1. Cannabinoid CB1 and CB2 Receptors, and Monoacylglycerol Lipase Gene Expression Alterations in the Basal Ganglia of Patients with Parkinson's Disease.
    Navarrete F; García-Gutiérrez MS; Aracil-Fernández A; Lanciego JL; Manzanares J
    Neurotherapeutics; 2018 Apr; 15(2):459-469. PubMed ID: 29352424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The therapeutic role of cannabinoid receptors and its agonists or antagonists in Parkinson's disease.
    Han QW; Yuan YH; Chen NH
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jan; 96():109745. PubMed ID: 31442553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of GPR55 and either cannabinoid CB
    Martínez-Pinilla E; Rico AJ; Rivas-Santisteban R; Lillo J; Roda E; Navarro G; Lanciego JL; Franco R
    Brain Struct Funct; 2020 Sep; 225(7):2153-2164. PubMed ID: 32691218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of cannabinoid receptors CB1 and CB2 within basal ganglia output neurons in macaques: changes following experimental parkinsonism.
    Sierra S; Luquin N; Rico AJ; Gómez-Bautista V; Roda E; Dopeso-Reyes IG; Vázquez A; Martínez-Pinilla E; Labandeira-García JL; Franco R; Lanciego JL
    Brain Struct Funct; 2015 Sep; 220(5):2721-38. PubMed ID: 24972960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low Basal CB2R in Dopamine Neurons and Microglia Influences Cannabinoid Tetrad Effects.
    Liu QR; Canseco-Alba A; Liang Y; Ishiguro H; Onaivi ES
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33371336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB
    Navarro G; Borroto-Escuela D; Angelats E; Etayo Í; Reyes-Resina I; Pulido-Salgado M; Rodríguez-Pérez AI; Canela EI; Saura J; Lanciego JL; Labandeira-García JL; Saura CA; Fuxe K; Franco R
    Brain Behav Immun; 2018 Jan; 67():139-151. PubMed ID: 28843453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective Effect of JZL184 in MPP(+)-Treated SH-SY5Y Cells Through CB2 Receptors.
    Aymerich MS; Rojo-Bustamante E; Molina C; Celorrio M; Sánchez-Arias JA; Franco R
    Mol Neurobiol; 2016 May; 53(4):2312-9. PubMed ID: 25976369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential of the cannabinoid CB(2) receptor as a pharmacological target against inflammation in Parkinson's disease.
    Gómez-Gálvez Y; Palomo-Garo C; Fernández-Ruiz J; García C
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():200-8. PubMed ID: 25863279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoid receptor-dependent metabolism of 2-arachidonoylglycerol during aging.
    Pascual AC; Gaveglio VL; Giusto NM; Pasquaré SJ
    Exp Gerontol; 2014 Jul; 55():134-42. PubMed ID: 24768821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased tonic cannabinoid CB1R activity and brain region-specific desensitization of CB1R Gi/o signaling axis in mice with global genetic knockout of monoacylglycerol lipase.
    Navia-Paldanius D; Aaltonen N; Lehtonen M; Savinainen JR; Taschler U; Radner FP; Zimmermann R; Laitinen JT
    Eur J Pharm Sci; 2015 Sep; 77():180-8. PubMed ID: 26070239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential upregulation of the cannabinoid CB₂ receptor in neurotoxic and inflammation-driven rat models of Parkinson's disease.
    Concannon RM; Okine BN; Finn DP; Dowd E
    Exp Neurol; 2015 Jul; 269():133-41. PubMed ID: 25895887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating the Effects of Exogenous and Endogenous 2-Arachidonoylglycerol on Retinal CB1 Cannabinoid Receptors and Reactive Microglia in Naive and Diseased Retina.
    Papadogkonaki S; Spyridakos D; Lapokonstantaki E; Chaniotakis N; Makriyannis A; Malamas MS; Thermos K
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty acid amide hydrolase and monoacylglycerol lipase inhibitors produce anti-allodynic effects in mice through distinct cannabinoid receptor mechanisms.
    Kinsey SG; Long JZ; Cravatt BF; Lichtman AH
    J Pain; 2010 Dec; 11(12):1420-8. PubMed ID: 20554481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal changes of CB1 cannabinoid receptor in the basal ganglia as a possible structure-specific plasticity process in 6-OHDA lesioned rats.
    Chaves-Kirsten GP; Mazucanti CH; Real CC; Souza BM; Britto LR; Torrão AS
    PLoS One; 2013; 8(10):e76874. PubMed ID: 24116178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of CB₂ receptors in human nigral neurons that degenerate in Parkinson's disease.
    García MC; Cinquina V; Palomo-Garo C; Rábano A; Fernández-Ruiz J
    Neurosci Lett; 2015 Feb; 587():1-4. PubMed ID: 25481767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alleviation of Neuropathology by Inhibition of Monoacylglycerol Lipase in APP Transgenic Mice Lacking CB2 Receptors.
    Zhang J; Chen C
    Mol Neurobiol; 2018 Jun; 55(6):4802-4810. PubMed ID: 28733897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoacylglycerol lipase is a therapeutic target for Alzheimer's disease.
    Chen R; Zhang J; Wu Y; Wang D; Feng G; Tang YP; Teng Z; Chen C
    Cell Rep; 2012 Nov; 2(5):1329-39. PubMed ID: 23122958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoacylglycerol lipase (MAGL) inhibition attenuates acute lung injury in mice.
    Costola-de-Souza C; Ribeiro A; Ferraz-de-Paula V; Calefi AS; Aloia TP; Gimenes-Júnior JA; de Almeida VI; Pinheiro ML; Palermo-Neto J
    PLoS One; 2013; 8(10):e77706. PubMed ID: 24204926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological inhibition of 2-arachidonoilglycerol hydrolysis enhances memory consolidation in rats through CB2 receptor activation and mTOR signaling modulation.
    Ratano P; Petrella C; Forti F; Passeri PP; Morena M; Palmery M; Trezza V; Severini C; Campolongo P
    Neuropharmacology; 2018 Aug; 138():210-218. PubMed ID: 29842858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of cannabinoid CB1 receptor mRNA in basal ganglia of normal and parkinsonian human brain.
    Hurley MJ; Mash DC; Jenner P
    J Neural Transm (Vienna); 2003 Nov; 110(11):1279-88. PubMed ID: 14628192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.